Yucai Wang Selected Research

Yucai Wang Research Topics

Disease

70	Neoplasms (Cancer) 05/2024 - 01/2007
13	Lymphoma (Lymphomas) 05/2024 - 01/2019
12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 01/2020
11	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 01/2019
10	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 01/2019
9	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2011
8	Infections 05/2024 - 03/2016
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2019
7	Multiple Myeloma 04/2024 - 01/2016
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 01/2022
7	Hypoxia (Hypoxemia) 01/2023 - 01/2018
5	Cytokine Release Syndrome 11/2023 - 09/2020
5	Disease Progression 01/2023 - 03/2016
4	COVID-19 02/2024 - 09/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2019
4	Inflammation (Inflammations) 09/2023 - 11/2017
4	Neoplasm Metastasis (Metastasis) 10/2019 - 08/2014
4	Fanconi Anemia (Fanconi's Anemia) 06/2014 - 03/2012
4	Osteosarcoma (Osteogenic Sarcoma) 04/2014 - 01/2007
3	Neutropenia 03/2024 - 03/2016
3	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 01/2022
3	Starvation 08/2023 - 01/2018
3	Hodgkin Disease (Hodgkin's Disease) 04/2023 - 01/2018
2	Cytopenia 01/2024 - 06/2022
2	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2022
2	Neoplasm Micrometastasis 01/2023 - 01/2023
2	Stroke (Strokes) 12/2022 - 08/2010
2	Fibrosis (Cirrhosis) 06/2022 - 09/2018
2	Dysbiosis 01/2022 - 01/2022
2	Hyperthermia 01/2022 - 10/2020
2	Atrial Fibrillation 01/2022 - 01/2021
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 08/2010
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2021
2	cell-associated neurotoxicity 01/2022 - 11/2021
2	Body Weight (Weight, Body) 01/2021 - 10/2013
2	Fatigue 01/2020 - 07/2019

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2022
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2012
8	GoldIBA 01/2023 - 01/2012
7	ibrutinibIBA 01/2024 - 01/2020
7	Immune Checkpoint InhibitorsIBA 04/2023 - 07/2019
6	venetoclaxIBA 03/2024 - 01/2020
6	EnzymesIBA 10/2023 - 03/2013
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 05/2007
5	axicabtagene ciloleucelIBA 01/2023 - 01/2021
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 04/2014
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2022
4	ProdrugsIBA 01/2023 - 01/2018
4	AlbuminsIBA 01/2023 - 12/2016
4	Monoclonal AntibodiesIBA 01/2022 - 01/2007
4	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
4	Therapeutic UsesIBA 10/2019 - 02/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 01/2022
3	VaccinesIBA 02/2024 - 01/2007
3	CytokinesIBA 02/2024 - 01/2020
3	brexucabtagene autoleucelIBA 11/2023 - 06/2022
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2018
3	Carrier Proteins (Binding Protein)IBA 01/2023 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 11/2017
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2016
3	Programmed Cell Death 1 ReceptorIBA 12/2021 - 01/2018
3	LipidsIBA 04/2021 - 01/2019
3	PolymersIBA 02/2020 - 01/2018
3	Liposomes (Liposome)IBA 03/2019 - 05/2017
2	AntigensIBA 05/2024 - 02/2024
2	Methotrexate (Mexate)FDA LinkGeneric 02/2024 - 12/2022
2	mRNA VaccinesIBA 02/2024 - 12/2023
2	zanubrutinibIBA 01/2024 - 01/2022
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2023
2	Alkylating AgentsIBA 11/2023 - 04/2022
2	LigandsIBA 10/2023 - 07/2019
2	Metal-Organic FrameworksIBA 10/2023 - 12/2021
2	Collagenases (Collagenase)FDA Link 10/2023 - 01/2022
2	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2022
2	A-Form DNA (A-DNA)IBA 01/2023 - 01/2018
2	pirtobrutinibIBA 01/2023 - 11/2022
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2021
2	Betaine (C.B.B.)FDA Link 01/2022 - 04/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 10/2019
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2020
2	AcidsIBA 02/2020 - 01/2020
2	N-end cysteine peptide tumor-homing peptideIBA 12/2019 - 08/2019
2	Photosensitizing Agents (Photosensitizers)IBA 08/2019 - 02/2018

Therapy/Procedure

60	Therapeutics 05/2024 - 08/2010
10	Radiotherapy 05/2024 - 09/2014
10	Immunotherapy 11/2022 - 01/2007
9	Drug Therapy (Chemotherapy) 01/2024 - 01/2013
5	Aftercare (After-Treatment) 02/2024 - 01/2018
4	Photothermal Therapy 05/2023 - 01/2018
3	Phototherapy (Light Therapy) 01/2021 - 10/2019
2	Transplantation 02/2024 - 01/2022
2	Lasers (Laser) 05/2023 - 10/2020
2	Length of Stay 01/2023 - 12/2022
2	Oral Administration 01/2022 - 10/2013
2	Photochemotherapy (Photodynamic Therapy) 01/2020 - 12/2019
2	Intravenous Injections 01/2020 - 01/2018